Expertise in
22
conditions

Dr. Beth M. Beadle

Radiation Oncology
Stanford Hospital And Clinics
965 High St, 
Palo Alto, CA 
Expertise in
22
conditions
Stanford Hospital And Clinics
965 High St, 
Palo Alto, CA 

Overview

Beth Beadle is a Radiation Oncologist practicing medicine in Palo Alto, California.

Dr. Beadle is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, Laryngeal Cancer, and Tongue Cancer.

She is actively involved in clinical research, co-authoring 163 peer reviewed articles and participating in 4 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in TX

Hospital Affiliations

Stanford Health Care

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Valley Health
  • HMO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Stanford Hospital and Clinics
965 High St, Palo Alto, CA 94301
Other Locations
Stanford University
875 Blake Wilbur Dr, Palo Alto, CA 94304

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: August 27, 2026
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at 40 mg/m2 for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at 40 mg/m2 for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Enrollment Status: Suspended
Publish Date: June 25, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2/Phase 3
A Randomized Study of Topical Dilute Hypochlorite (Modified Dakin's Solution) Treatment for the Prevention of Radiation Dermatitis in Head and Neck Cancer
A Randomized Study of Topical Dilute Hypochlorite (Modified Dakin's Solution) Treatment for the Prevention of Radiation Dermatitis in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Drug, Other
Study Phase: Phase 3
View 3 Less Clinical Trials

163 Total Publications

Reply to: Therapeutic Strategy Concerns for BRAF V600E-Mutated Differentiated Thyroid Cancer.
Reply to: Therapeutic Strategy Concerns for BRAF V600E-Mutated Differentiated Thyroid Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 06, 2026
Similar Doctors
Expertise in
15
conditions
Dr. Richard T. Hoppe
Radiation Oncology
Expertise in
15
conditions
Dr. Richard T. Hoppe
Radiation Oncology
Referral may be required

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (0.1 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Richard Hoppe is a Radiation Oncologist practicing medicine in Palo Alto, California. Dr. Hoppe is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Mycosis Fungoides, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Cutaneous T-Cell Lymphoma (CTCL).

Expertise in
9
conditions
Dr. Maximilian Diehn
Radiation Oncology
Expertise in
9
conditions
Dr. Maximilian Diehn
Radiation Oncology
Referral may be required

Stanford University

875 Blake Wilbur Dr, 
Palo Alto, CA 
 (1.1 miles away)
650-723-6171
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Maximilian Diehn is a Radiation Oncologist practicing medicine in Palo Alto, California. Dr. Diehn is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.

Expertise in
45
conditions
Dr. Scott G. Soltys
Radiation Oncology
Expertise in
45
conditions
Dr. Scott G. Soltys
Radiation Oncology
Referral may be required

Stanford University

875 Blake Wilbur Dr, 
Palo Alto, CA 
 (1.1 miles away)
650-724-1569
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Scott Soltys is a Radiation Oncologist practicing medicine in Palo Alto, California. Dr. Soltys is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Metastatic Brain Tumor, Astrocytoma, Acoustic Neuroma, and Rhizotomy.

Frequently Asked Questions about Dr. Beth M. Beadle

How do I make an appointment with Dr. Beth M. Beadle?

You can book an appointment with Dr. Beth M. Beadle by calling their office at 650-723-6197. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Beth M. Beadle a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Beth M. Beadle is classified as an Elite expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Beth M. Beadle specialize in?

While Dr. Beth M. Beadle is a Radiation Oncology, they have specific expertise in Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, and Laryngeal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Beth M. Beadle participate in research or clinical trials?

Yes. Dr. Beth M. Beadle has published 163 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Dr. Beth M. Beadle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Beth M. Beadle accept my insurance?

Dr. Beth M. Beadle accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 650-723-6197 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Beadle's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 10 Advanced Conditions
View All 43 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile